300358 Truking Technology
- 8.31
- -0.28-3.26%
Truking Technology News
Chutian Technology (300358): Steady revenue growth in 2023
Incident: The company released the 2023 report and the 2024 quarterly report. In 2023, it achieved revenue of 6.85 billion yuan, +6.3% year-on-year, and realized net profit of 320 million yuan, or -44.1% year-on-year, after deducting 3.1 billion yuan in net profit not attributable to mother
Chutian Technology (300358.SZ): The company provides intelligent overall solutions for global pharmaceutical production customers, involving a wide range of drugs
Gelonghui, May 9丨Chutian Technology (300358.SZ) said on the investor interactive platform that the company provides global pharmaceutical production customers with intelligent overall solutions, involving a wide range of drugs. Insulin cell culture is only one type of drug. It involves fermentation, dosing, centrifugation, ultrafiltration, low-pressure chromatography, high-pressure chromatography, freeze-drying, filling, injection pen assembly, packaging, etc. We can provide equipment and services according to the actual needs of customers. It is part of the company's existing products. The specific data is based on the product sales data announced in the company's regular reports. Investors are requested to pay attention to investment risks and invest rationally.
Chutian Technology (300358.SZ): Reactors and other related equipment and consumables involved in the synthetic biology sector can be provided according to customer needs
Gelonghui, May 9 | Chutian Technology (300358.SZ) said on the investor interactive platform that related equipment and consumables such as reactors, purification systems, liquid dispensing systems, centrifugal separation systems, disposable bags, fillers, etc. involved in the synthetic biology sector can all be provided according to customer needs.
Express News | The ban on restricted shares with a market capitalization of 66.797 billion yuan was lifted today
A-share changes | Chutian Technology plummeted by more than 11%, Q1 net profit fell 116% year on year, profit and loss
Gelonghui, April 25 | Chutian Technology (300358.SZ) fell sharply by more than 11% to 7.64 yuan, with a total market value of 4.51 billion yuan. The company announced yesterday after the market that revenue for the first quarter was 1,392 million yuan, a year-on-year decrease of 10.39%; net loss attributable to shareholders of listed companies was 208.717 million yuan, a year-on-year profit and loss. Basic earnings per share - 0.0354 yuan/share. Also, yesterday, 173,300 shares were sold by foreign investors. Up to now, Land Stock Connect holds 3.643,800 shares of Chutian Technology.
The China Securities Convertible Bond Index opened up 0.04%. Daye Convertible Bonds rose by more than 11%, Mid-Term Transfer 2 rose by more than 8%, and Chutian Convertible fell 1.51%.
The China Securities Convertible Bond Index opened up 0.04%. Daye Convertible Bonds rose by more than 11%, Mid-Term Transfer 2 rose by more than 8%, and Chutian Convertible fell 1.51%.
Chutian Technology (300358): Bioengineering leads growth, price competition intensifies short-term pressure on performance
Incident: The company released its annual report for the year 20223 and the quarterly report for 2024. In 2023, it achieved operating income of 6.853 billion yuan (yoy +6%), and realized net profit of 317 million yuan (yoy -44%), deducting non-return to mother
Chutian Technology (300358.SZ) announced first-quarter results, with a net loss of 208.717 million yuan, a year-on-year profit to loss
Chutian Technology (300358.SZ) released its report for the first quarter of 2024, with revenue of 1,392 billion yuan,...
Chutian Technology (300358.SZ) once again passed the high-tech enterprise certification
Gelonghui, April 9, 丨 Chutian Technology (300358.SZ) announced that the company recently received the “High-tech Enterprise Certificate” jointly issued by the Hunan Provincial Department of Science and Technology, the Hunan Provincial Department of Finance, and the Hunan Provincial Taxation Bureau of the State Administration of Taxation. The company once again passed the certification of a high-tech enterprise. Certificate number GR202343005519; issued on December 8, 2023; valid for three years.
Express News | Chutian Technology and CICC officially signed a joint irradiation technology project to build an irradiation technology project
Express News | Chutian Technology and CICC irradiated 80 million yuan to establish a health technology company
The controlling shareholder of Chutian Technology (300358.SZ) increased its holdings by 657,400 shares
Chutian Technology (300358.SZ) announced that as of March 25, 2024, the planned time to increase holdings is over half...
Analysis of listing pricing of Chutian Convertible Bonds
Summary Chutian Convertible Bonds will be listed on February 29 (Thursday), with a scale of 1 billion yuan, and a conversion rating of AA. According to our new securities pricing model, we believe that in the current situation of the company's stock price, the bond conversion listing position may be 120.7
Chutian Technology (300358.SZ): “Chutian Bonds Transfer” will be listed for trading on February 29
Zhitong Finance App News, Chutian Technology (300358.SZ) announced that the company's 1 billion yuan convertible corporate bond will be listed and traded on the Shenzhen Stock Exchange from February 29, 2024. The bonds are abbreviated as “Chutian Convertible Bonds”, and the bond code is “123240.”
Chutian Technology (300358.SZ): Can provide customers with design, purification, water treatment, intelligent storage, etc.
Gelonghui, January 29丨Chutian Technology (300358.SZ) said on the investor interactive platform that in biopharmaceutical-related products, the company can provide customers with overall personalized solutions covering design, purification, separation and purification, distribution, post-testing packaging, intelligent storage, etc., from front to back.
Chutian Technology (300358.SZ): The subsidiary Chutian Pete can provide global customers with solutions related to peptide synthesis
Gelonghui, January 29丨Chutian Technology (300358.SZ) said on the investor interactive platform that the company's subsidiary Chutian Pete can provide customers around the world with solutions related to peptide synthesis, and at the same time, our company can also provide equipment related to synthetic organisms such as reactors. The above equipment and solutions can be customized and produced and sold according to customer needs.
Chutian Technology (300358): The industrial chain is gradually improving, and we look forward to innovation and breaking the game
Financial performance: Revenue was basically flat month-on-month, profit was under short-term pressure 2023Q1-Q3: The company achieved operating income of 5.134 billion yuan, an increase of 14.22% over the previous year; realized net profit of 287 million yuan, a year-on-year decrease of 3 million yuan
Chutian Technology: The subsidiary provides global customers with solutions related to peptide synthesis
Gelonghui, December 29 | Chutian Technology said on an interactive platform that the company's subsidiary Chutian Pete can provide customers around the world with solutions related to peptide synthesis, while our company can also provide equipment related to synthetic organisms such as reactors.
Chutian Technology (300358): The rapid growth of bioengineering industry chain layout continues to be implemented
Bioengineering revenue grew rapidly, and operations increased steadily in the first three quarters of 2023. In the first three quarters of 2023, the company achieved revenue of 5.134 billion yuan, an increase of 14.22% over the previous year; by business sector, bioengineering, aseptic preparations, testing and packaging, and solid preparations
Chutian Technology (300358.SZ)'s application to issue convertible corporate bonds to unspecified targets was reviewed and approved by the Shenzhen Stock Exchange
According to the Zhitong Finance App, Chutian Technology (300358.SZ) issued an announcement. On November 23, 2023, the Shenzhen Stock Exchange Listing Review Committee held the 85th Listing Review Committee review meeting in 2023 to review the company's application to issue convertible corporate bonds to unspecified targets. According to the review results of the conference, the company's application to issue convertible corporate bonds to an unspecified target met the issuance conditions, listing conditions, and information disclosure requirements. Furthermore, the company's issuance of convertible corporate bonds to an unspecified target is still subject to the registration procedure of the China Securities Regulatory Commission.
Analysis
Price Target
No Data
